Next Level Clinical Trials, LLC

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Autism2 trials
• Bipolar disorder2 trials
• Depression1 trial
• Schizophrenia1 trial

Phase

• Phase 34 trials

Status

• Recruiting3 trials
• Completed1 trial

Lead sponsor

• Intra-Cellular Therapies, Inc.3 trials
• Janssen Research & Development, LLC1 trial

Running trials

• Recruiting

  Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

  NCT06690398· Phase 3· Intra-Cellular Therapies, Inc.· Source

• Recruiting

  Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

  NCT06372964· Phase 3· Intra-Cellular Therapies, Inc.· Source

• Recruiting

  Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  NCT06229210· Phase 3· Intra-Cellular Therapies, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Autism2 recruiting
• Bipolar disorder2 recruiting
• Schizophrenia1 recruiting

Closed trials

• Completed

  A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

  NCT05550532· Phase 3· Janssen Research & Development, LLC· Source